•  
  •  
  •  
  •  

2025-12-23 13:05:39

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  CapitalTrust

Stock Report

  • Capital Trust Ltd successfully completes Rights Issue
  • Capital Trust Ltd enters Gold Loan Business, Opens First Branch in Aligarh, Uttar Pradesh
  • Capital Trust Ltd commences Gold Loan business
  • Capital Trust Limited partners with CBV Ventures to Power Credit Enablement for FMCG Distribution Hubs and Retailers
  • Capital Trust Ltd strengthens leadership team to drive secured MSME Business
  • Capital Trust Limited ventures into secured loans
  • Capital Trust Granted RBI Authorization for Aadhaar Authentication Under MoneyLaundering Act
  • Capital Trust Ltd Q2FY23 consolidated profit up at Rs. 2.01 crore
  • Capital Trust Ltd consolidated Q1FY23 profit climbs to Rs. 1.94 crore
  • Capital Trust Ltd reports Rs. 1.62 crore consolidated net profit in Q4 FY2021-22
  • Capital Trust Limited attains highest quarterly disbursements post-COVID for Q4FY2022
  • Capital Trust to leverage Capital Digital Loans to drive profitable growth
  • Capital Trust Ltd Q3FY22 consolidated PAT up at Rs. 95.83 lakhs
  • Capital Trust Ltd pledges to accelerate Digital Lending to Scale up Financial Inclusion in India
  • CARE assigns ratings to borrowings of Capital Trust Limited

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024